Literature DB >> 9692092

Alpha 1-antitrypsin deficiency in Europe: geographical distribution of Pi types S and Z.

D C Hutchison1.   

Abstract

alpha 1-Antitrypsin (AT) is the principal serum inhibitor of proteolytic enzymes such as neutrophil elastase. AT can exist as over 90 different genetically determined variants known as the Pi system; the three most important variants are type M (90% of population) and types S and Z, two of the commoner abnormal variants. Homozygotes of type Z have a severe reduction in the serum AT concentration and may develop pulmonary emphysema or hepatic cirrhosis. Heterozygotes of type SZ have a less severe reduction in serum AT concentration and the association with clinical disease is less clear. The S and Z variants are found mainly among those of European stock. The gene frequency for Pi type Z is highest on the north-western seaboard of the continent and the mutation seems likely to have arisen in southern Scandinavia. The distribution of type S is quite different; the gene frequency is highest in the Iberian peninsula and the mutation is likely to have arisen in that region. A population survey for determining the number of type Z homozygotes in a given community is important for planning purposes now that AT replacement therapy is potentially available.

Entities:  

Mesh:

Year:  1998        PMID: 9692092     DOI: 10.1016/s0954-6111(98)90278-5

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  22 in total

Review 1.  Alpha-1 antitrypsin deficiency.

Authors:  R A Primhak; M S Tanner
Journal:  Arch Dis Child       Date:  2001-07       Impact factor: 3.791

2.  Rapid and inexpensive detection of alpha1-antitrypsin deficiency-related alleles S and Z by a real-time polymerase chain reaction suitable for a large-scale population-based screening.

Authors:  Marcin P Kaczor; Marek Sanak; Andrew Szczeklik
Journal:  J Mol Diagn       Date:  2007-02       Impact factor: 5.568

3.  Diagnosing alpha-1 antitrypsin deficiency: does it prevent or improve the course of COPD?

Authors:  Irma Godoy
Journal:  J Bras Pneumol       Date:  2016 Sep-Oct       Impact factor: 2.624

4.  Cutoff level to detect heterozygous alpha 1 antitrypsin deficiency in Turkish population.

Authors:  Halis Simsek; Aslı Pinar; Akif Altinbas; Alparslan Alp; Yasemin H Balaban; Yahya Buyukasik; Osman Ozcebe; Gulsen Hascelik; Gokhan Gedikoglu; Gonca Tatar
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

Review 5.  Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency.

Authors:  M Luisetti; N Seersholm
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

Review 6.  Genetics of pancreatitis: a guide for clinicians.

Authors:  Matthias Treiber; Christoph Schlag; Roland M Schmid
Journal:  Curr Gastroenterol Rep       Date:  2008-04

Review 7.  Alpha-1 antitrypsin deficiency: a conformational disease associated with lung and liver manifestations.

Authors:  C M Greene; S D W Miller; T Carroll; C McLean; M O'Mahony; M W Lawless; S J O'Neill; C C Taggart; N G McElvaney
Journal:  J Inherit Metab Dis       Date:  2008-01-16       Impact factor: 4.982

Review 8.  Alpha-1-antitrypsin deficiency: increasing awareness and improving diagnosis.

Authors:  Timm Greulich; Claus F Vogelmeier
Journal:  Ther Adv Respir Dis       Date:  2015-09-04       Impact factor: 4.031

Review 9.  Chronic pancreatitis and cystic fibrosis.

Authors:  H Witt
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

10.  Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency.

Authors:  Irina Petrache; Joud Hajjar; Michael Campos
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.